MFC Co., Ltd. (KOSE: A432980)
Health Care · Pharmaceuticals · KR
₩2,555.00
-2.11% today · -35.1% 1Y
MFC Co., Ltd. (KOSE: A432980) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.33M.
Over the last twelve months the share price has lost 35.1%, trading between 2.31K and 4.53K.
Tweenvest scores MFC Co., Ltd. across four factors: quality 66/100, value 62/100, growth 35/100. Its strongest factor is quality.
A432980 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.33M
- Revenue (TTM)
- $12.08M
- P/E
- —
- EPS
- -145.37
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩4,530.00
- 52-week low
- ₩2,305.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.59M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Curis Lifesciences LimitedNSEI: CURIS | $16.88M | Rs202.00 | -2.18% |
| Seoul Pharma Co., LtdKOSDAQ: A018680 | $16.76M | ₩1,933.00 | -0.26% |
| Kimia Biosciences LimitedBSE: 530313 | $16.67M | Rs34.10 | +10.00% |
| PuraPharm Corporation LimitedSEHK: 1498 | $16.50M | HK$0.24 | -5.10% |
| Rocket One Inc.NasdaqCM: RKTO | $16.17M | $0.65 | -6.94% |
| Kiora Pharmaceuticals, Inc.NasdaqCM: KPRX | $16.16M | $2.54 | -0.78% |
| Devonian Health Group Inc.TSXV: GSD | $16.08M | CA$8.25 | +3.13% |
| Peak Processing LimitedASX: PKP | $15.83M | AU$0.02 | +6.25% |
Figures last refreshed Oct 11, 2026.